VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Jun 14, 2022
Document Date
Jun 14, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Mitchell Stephen Ray
Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |